Abstract:Abstract Breast cancer is a leading cause of cancer-related death among American women. The etiology of majority of breast cancers is multifactorial, of which 95% is environmental and hormonal. Polycyclic aromatic hydrocarbons (PAHs) are commonly found in our environment and appear to be carcinogenic by genotoxic mechanisms. The taxanes are the most unique and successful chemotherapeutic agents used for the treatment of breast and ovarian cancer. However, multi-drug resistance (MDR) is one of the primary obstacles for successful chemotherapy. Drug metabolizing enzymes (DMEs) and transporters play important roles in modulating drug absorption, distribution, metabolism, and elimination. The regulation of gene expression of DMEs and transporters has potential impact on drug interactions of many therapeutic agents. P-glycoprotein (P-gp), Pregnane X receptor (PXR), and CYP3A are associated with MDR in breast cancer chemotherapy. Taxanes induce CYP3A by activating PXR-mediated transcription and enhance P-gp mediated drug clearance in human mammary tumor cells. Recent studies involving drug-phytochemical interactions, in addition to interactions among dietary micronutrients, indicate possibilities for improved therapeutic strategies. It is estimated that roughly 50% of cancer patients use some kind of dietary supplements. In the present study, we evaluated the ability of dietary and chemopreventive phytochemicals (curcumin and sulforaphane) on reversal of MDR induced by taxanes (paclitaxel and docetaxel). We also assessed the effects of dietary phytochemicals and taxanes, alone or in combination, on the gene expression of various DMEs, transporters, and receptors in female C57BL/6J mice exposed to the environmental PAH, 7, 12-dimethylbenz(a)anthracene (DMBA). The dietary phytochemicals suppressed the hepatic and mammary gene expression of Phase 1 (CYP1A1, 1B1) DMEs and elevated the levels of Phase 2 (NQO1) DMEs. The hepatic gene expression of CYP3A11, PXR, aryl hydrocarbon receptor and mammary gene expression of P-gp were induced in female mice exposed to DMBA and chemotherapeutic drugs (paclitaxel and docetaxel). Administration of curcumin and sulforaphane inhibited the induced gene expression levels significantly. Treatment of mice with a combination of curcumin and sulforaphane was more effective compared to treatment with either curcumin or sulforaphane alone. The differential regulation of gene expression levels reveal the potential of phytochemicals to reverse MDR in breast cancer chemotherapy. These studies will help in development of effective pharmacotherapeutic based strategies for preventing and treating human breast cancer. The studies will also lead to the development of novel combination drugs that can be used for successful chemotherapy of breast cancer in women. Citation Format: Sudha Kondraganti, Lihua Wang, Weiwu Jiang, Bhagavatula Moorthy. Regulation of drug metabolizing enzyme and transporter gene expression by dietary and chemopreventive phytochemicals in breast cancer. [abstract]. In: Proceedings of the 105th Annual Meeting of the American Association for Cancer Research; 2014 Apr 5-9; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2014;74(19 Suppl):Abstract nr 769. doi:10.1158/1538-7445.AM2014-769

Diallyl Disulfide and Diallyl Trisulfide in Garlic As Novel Therapeutic Agents to Overcome Drug Resistance in Breast Cancer

Updates on the anticancer potential of garlic organosulfur compounds and their nanoformulations: Plant therapeutics in cancer management

Diallyl disulfide inhibits growth and metastatic potential of human triple-negative breast cancer cells through inactivation of the β-catenin signaling pathway.

Anticancer effects of garlic and garlic-derived compounds for breast cancer control

Diallyl Disulfide Suppresses SRC/Ras/ERK Signaling-Mediated Proliferation and Metastasis in Human Breast Cancer by Up-Regulating Mir-34A

Effects of Garlic on Breast Tumor Cells with a Triple Negative Phenotype: Peculiar Subtype-Dependent Down-Modulation of Akt Signaling

Diallyl Sulfide, Diallyl Disulfide and Diallyl Trisulfide Affect Drug Resistant Gene Expression in Colo 205 Human Colon Cancer Cells in Vitro and in Vivo

Diallyl Disulfide Suppresses SRC/Ras/ERK Signaling-Mediated Proliferation and Metastasis in Human Breast Cancer by Up-Regulating Mir-34A.

Novel Anti-Carcinogenic Activity of an Organosulfide from Garlic: Inhibition of H-Ras Oncogene Transformed -Tumor Growth in Vivo by Diallyl Disulfide is Associated with Inhibition of P21(H-Ras) Processing

A comprehensive understanding about the pharmacological effect of diallyl disulfide other than its anti-carcinogenic activities

Allicin Overcomes Doxorubicin Resistance of Breast Cancer Cells by Targeting the Nrf2 Pathway

Diallyl Sulfide, Diallyl Disulfide and Diallyl Trisulfide Inhibit Ras, ERK, JNK, Cox‐2 and NF‐κB Led to Decrease MDR and Mrps Expressions in Human Colon Cancer Colo 205 Cells

Diallyl Trisulfide Inhibits Growth Of Nci-H460 In Vitro And In Vivo, And Ameliorates Cisplatin-Induced Oxidative Injury In The Treatment Of Lung Carcinoma In Xenograft Mice

The Garlic Compound, Diallyl Trisulfide, Attenuates Benzo[a]Pyrene-Induced Precancerous Effect through Its Antioxidant Effect, AhR Inhibition, and Increased DNA Repair in Human Breast Epithelial Cells

Abstract 769: Regulation of Drug Metabolizing Enzyme and Transporter Gene Expression by Dietary and Chemopreventive Phytochemicals in Breast Cancer

Abstract 4692: A novel ceramide synthase 2 agonist and its implication in triple-negative breast cancer therapy

Diallyl Trisulfide Suppresses Tumor Growth Through the Attenuation of Nrf2/Akt and Activation of P38/jnk and Potentiates Cisplatin Efficacy in Gastric Cancer Treatment

Diallyl Disulfide Inhibits Breast Cancer Stem Cell Progression and Glucose Metabolism by Targeting CD44/PKM2/AMPK Signaling.

The Anticancer Effects of the Garlic Organosulfide Diallyl Trisulfide through the Attenuation of B[a]P-Induced Oxidative Stress, AhR Expression, and DNA Damage in Human Premalignant Breast Epithelial (MCF-10AT1) Cells

Allicin: a promising modulator of apoptosis and survival signaling in cancer

Diallyl Disulfide Inhibits the Metastasis of Type Ⅱ Esophageal‑gastric Junction Adenocarcinoma Cells Via NF-κB and PI3K/AKT Signaling Pathways in Vitro.